Search research articles
Contact Us
Filters
Showing results (421-430 of 476) with videos related to
Page
of 48
Sort By:
The American Journal of Physiology
|
November 1, 1987
Increased lymphocyte transport by lipid absorption in rat mesenteric lymphatics
S Miura, E Sekizuka, H Nagata, et al.
Thrombosis and Haemostasis
|
April 1, 1994
Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome
M Yamazaki, H Asakura, H Jokaji, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma
T Ichida, M Kato, A Hayakawa, et al.
The American Journal of Gastroenterology
|
January 19, 2000
The striking effect of hyperbaric oxygenation therapy in the management of chronic idiopathic intestinal pseudo-obstruction
T Yokota, T Suda, S Tsukioka, et al.
Journal of Clinical & Laboratory Immunology
|
February 1, 1988
T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis; a morphometric and immunohistochemical study
K Kobayashi, H Asakura, Y Hamada, et al.
Scandinavian Journal of Gastroenterology
|
January 5, 2002
Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes
K Suzuki, K Sugimura, K Hasegawa, et al.
Japanese Journal of Cancer Research : Gann
|
February 27, 2001
Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum
S Yamada, Y Ajioka, H Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 1998
The primary site of CD4- 8- B220+ alphabeta T cells in lpr mice: the appendix in normal mice
S Yamagiwa, S Sugahara, T Shimizu, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study
T Ichida, M Kato, A Hayakawa, et al.
Thrombosis Research
|
June 15, 1991
Prothrombin Himi; an abnormal prothrombin characterized by a defective thrombin activity
E Morishita, M Saito, H Asakura, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 476) with videos related to
Sort By:
Page
of 48
The American Journal of Physiology
|
November 1, 1987
Increased lymphocyte transport by lipid absorption in rat mesenteric lymphatics
S Miura, E Sekizuka, H Nagata, et al.
Thrombosis and Haemostasis
|
April 1, 1994
Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome
M Yamazaki, H Asakura, H Jokaji, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma
T Ichida, M Kato, A Hayakawa, et al.
The American Journal of Gastroenterology
|
January 19, 2000
The striking effect of hyperbaric oxygenation therapy in the management of chronic idiopathic intestinal pseudo-obstruction
T Yokota, T Suda, S Tsukioka, et al.
Journal of Clinical & Laboratory Immunology
|
February 1, 1988
T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis; a morphometric and immunohistochemical study
K Kobayashi, H Asakura, Y Hamada, et al.
Scandinavian Journal of Gastroenterology
|
January 5, 2002
Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes
K Suzuki, K Sugimura, K Hasegawa, et al.
Japanese Journal of Cancer Research : Gann
|
February 27, 2001
Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum
S Yamada, Y Ajioka, H Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 1998
The primary site of CD4- 8- B220+ alphabeta T cells in lpr mice: the appendix in normal mice
S Yamagiwa, S Sugahara, T Shimizu, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study
T Ichida, M Kato, A Hayakawa, et al.
Thrombosis Research
|
June 15, 1991
Prothrombin Himi; an abnormal prothrombin characterized by a defective thrombin activity
E Morishita, M Saito, H Asakura, et al.
Page
of 48